Stock listing
NASDAQ:CELG Celgene Corporation Stock
Follow Celgene Corporation into a list and get an email when it puts out news.
Last close · NASDAQ:CELG
$108.24 USD
Close on Nov 20, 2019 · No longer trades
- Lowest – highest close
- $59.21 – $146.52 USDSince Jun 26, 2014 · lowest Dec 24, 2018 · highest Oct 4, 2017
Delisted NASDAQ:CELG no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:CELG
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Celgene Corporation on 6ix
- Decks
- 11 decks · latest Mar 25, 2019
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (March 2019) | Merger or acquisition | 25 slides | Mar 25, 2019 |
| Merger or Acquisition (March 2019) | Merger or acquisition | 107 slides | Mar 19, 2019 |
| Merger or Acquisition (March 2019) | Merger or acquisition | 46 slides | Mar 6, 2019 |
| Merger or Acquisition (February 2019) | Merger or acquisition | 37 slides | Feb 20, 2019 |
| FY2018 Earnings Presentation | Earnings | 54 slides | Jan 31, 2019 |
| Merger or Acquisition (January 2019) | Merger or acquisition | 26 slides | Jan 3, 2019 |
| Proxy Contest (May 2018) | Proxy contest | 28 slides | May 18, 2018 |
| Merger or Acquisition (January 2018) | Merger or acquisition | 23 slides | Jan 22, 2018 |
| Shareholder Meeting (May 2016) | Shareholder meeting | 19 slides | May 10, 2016 |
| Merger or Acquisition (July 2015) | Merger or acquisition | 29 slides | Jul 15, 2015 |
All 11 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (May 2014) | Shareholder meeting | 21 slides | May 20, 2014 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Carrie S. Cox Other companies: Solventum Corporation (Director · Since at least Apr 1, 2024); Organon & Co. (Executive Board Chair · Since at least Jun 2, 2021); Texas Instruments Incorporated (Director · Since at least Jul 28, 2015); Cartesian Therapeutics, Inc. (Director · Nov 20, 2019 – Jan 2, 2025 · Past); electroCore, Inc. (Director · Jun 21, 2018 – Jun 7, 2019 · Past); Cardinal Health, Inc. (Director · Nov 4, 2015 – Nov 9, 2022 · Past) | Director · Jul 1, 2015 – Nov 20, 2019 · Past |
| Alise Reicin Other companies: Immatics N.V. (Director · Since at least Mar 18, 2026); Tectonic Therapeutic, Inc. (President and CEO, Director · Since at least Jun 20, 2024); Sana Biotechnology, Inc. (Director · Since at least Feb 3, 2021); Q32 Bio Inc. (Director · Jul 11, 2019 – Jun 14, 2023 · Past) | PRES., GLOBAL CLINICAL DEV. · Nov 1, 2018 – Nov 20, 2019 · Past |
| Hans Bishop Other companies: Sana Biotechnology, Inc. (Chairman · Since at least Feb 3, 2021); Lyell Immunopharma, Inc. (Director · Jun 16, 2021 – Jun 14, 2024 · Past); Agilent Technologies, Inc. (Director · Jul 18, 2017 – Mar 15, 2024 · Past); Juno Therapeutics Inc (CEO & President, Director · Jun 9, 2016 – Mar 5, 2018 · Past) | Director · Apr 18, 2018 – Nov 20, 2019 · Past |
| John H. Weiland Other companies: Solventum Corporation (Director · Since at least Apr 1, 2024); Cardinal Health, Inc. (Director · Sep 1, 2019 – Nov 11, 2021 · Past); West Pharmaceutical Services, Inc. (Director · Jun 30, 2015 – May 1, 2018 · Past) | Director · Feb 13, 2018 – Nov 20, 2019 · Past |
| Julia A. Haller Other companies: Outlook Therapeutics, Inc. (Director · Since at least Aug 11, 2022); Bristol-Myers Squibb Company (Ophthalmologist-in-Chief, Wills Eye Hospital · Since at least Nov 20, 2019); Hyperion DeFi, Inc. (Director · Mar 31, 2021 – Jun 16, 2022 · Past) | Director · Oct 15, 2015 – Nov 20, 2019 · Past |
| Mark J Alles Other companies: BioMarin Pharmaceutical Inc. (Director · Jan 1, 2022 – May 23, 2023 · Past); Turning Point Therapeutics Inc (Director · May 24, 2021 – Aug 17, 2022 · Past); Syros Pharmaceuticals, Inc. (Director · Dec 19, 2019 – Sep 16, 2023 · Past) | CEO, CHAIRMAN OF BOARD, Director · Feb 15, 2012 – Nov 20, 2019 · Past |
| Nadim Ahmed Other companies: Disc Medicine, Inc. (Director · Since at least Jul 14, 2025); Cullinan Therapeutics, Inc. (President and CEO, Director · Since at least Oct 18, 2021); Bristol-Myers Squibb Company (EVP and President, Hematology · Nov 20, 2019 – Dec 31, 2020 · Past) | PRES., GLOBAL HEM. AND ONC. · Jun 13, 2018 – Nov 20, 2019 · Past |
| Jonathan Biller Other companies: Vertex Pharmaceuticals Incorporated (EVP and Chief Legal Officer · Since at least Sep 19, 2022); Agios Pharmaceuticals, Inc. (Chief Financial Officer · Dec 3, 2019 – Mar 1, 2022 · Past) | EVP AND GENERAL COUNSEL · Jul 3, 2018 – Nov 20, 2019 · Past |
| Lawrence V Stein | See Remarks · Nov 26, 2012 – May 14, 2015 · Past |
Log in to ask 6ix AI your own questions about Celgene Corporation.